In silico antigenic and vaccinological characterization of two production-optimized recombinant yellow fever virus envelope proteins

Elif Naz Bingöl, Gioacchin Iannolo, Rosaria Tinnirello, Adam Gillman, Jesús Reiné, Chiuan Yee Leow, Chiuan Herng Leow, Asif M. Khan, Ester Badami, Bruno Douradinha
Virus Research · Elsevier · DOI: 10.2139/ssrn.7468064

Abstract

Yellow fever virus (YFV) remains a major public health threat in endemic regions of Africa and South America. Although the live-attenuated YFV 17D vaccine is highly effective, its use is contraindicated or requires careful risk assessment in some vulnerable populations, supporting the development of nonreplicating vaccine alternatives and improved antigenic tools. In this study, we performed an integrated in silico comprehensive characterization of two production-optimized recombinant YFV envelope (Env) proteins derived from the Asibi and 17D strains. Physicochemical, antigenicity, solubility, allergenicity, proteolytic-sensitivity, epitope-conservancy, structural-modeling, conformational B-cell epitope, molecular-docking, molecular-dynamics (MD), electrostatic-interface, and immune-simulation analyses were used to evaluate their structural and immunological properties. Both Env proteins were predicted to be antigenic, hydrophilic, structurally stable, and compatible with recombinant antigen development, although allergenicity predictions were partially discordant for the 17D-derived antigen. Epitope mapping identified multiple predicted CD8⁺ and CD4⁺ T-cell epitopes, conserved linear B-cell epitopes, and conformational antibody-accessible regions. Conservation analyses showed that many predicted T-cell epitopes were maintained across representative YFV strains, whereas predicted B-cell epitopes displayed greater strain-associated variability. Structural modeling suggested that both proteins can adopt native-like dimeric conformations, while molecular-docking and MD simulations with the neutralizing YFV antibody YD6 supported the preservation and stability of conformational surfaces compatible with antibody engagement. Immune simulations predicted coordinated adaptive responses after repeated immunization. Overall, these findings support further experimental evaluation of recombinant YFV Asibi Env and YFV 17D Env as nonreplicating vaccine antigens, diagnostic reagents, and tools for investigating YFV antigenicity and immune responses.

Read at publisher →

Similar articles